BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38350902)

  • 1. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
    Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
    BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 5. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
    Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
    Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway.
    Huang ML; Zou Y; Yang R; Jiang Y; Sheng JF; Han JB; Kong YG; Tao ZZ; Chen SM
    Exp Cell Res; 2019 Jan; 374(1):172-180. PubMed ID: 30496758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway.
    Xia X; Zhao S; Chen W; Xu C; Zhao D
    Ir J Med Sci; 2023 Dec; 192(6):2653-2660. PubMed ID: 37017854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
    Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
    Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
    Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT.
    Xiao J; Zhou N; Li Y; Xiao Y; Chen W; Ye J; Ma T; Zhang Y
    Biomed Pharmacother; 2020 Oct; 130():110743. PubMed ID: 34321176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISP1 aggravates cell metastatic potential by abrogating TGF-
    Song D; Wang L; Su K; Wu H; Li J
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
    Oh MK; Joo H; Kim IS
    PLoS One; 2022; 17(5):e0266409. PubMed ID: 35580109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
    Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
    BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-
    Xue Q; Jiang H; Wang J; Wei D
    Can Respir J; 2021; 2021():5277409. PubMed ID: 34912481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.